Skip to Content

APO 116 (Terazosin Hydrochloride 2 mg)

Pill with imprint APO 116 is Yellow, Capsule-shape and has been identified as Terazosin Hydrochloride 2 mg. It is supplied by Apotex Corp..

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO 116

Terazosin hydrochloride 2 mg APO 116
Terazosin hydrochloride 2 mg APO 116 Front
Terazosin hydrochloride 2 mg APO 116 Back
Terazosin hydrochloride 2 mg APO 116
Terazosin hydrochloride 2 mg APO 116

Terazosin Hydrochloride

Imprint
APO 116
Strength
2 mg
Color
Yellow
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
National Drug Code (NDC)
60505-0116
Inactive Ingredients
lactose monohydrate, corn starch, stearic acid, magnesium silicate, ammonia, ferrosoferric oxide, potassium hydroxide, propylene glycol, shellac, D&C Yellow No. 10, FD&C Red No. 40, gelatin, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.